These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18246195)

  • 1. Stressed out: the skeletal muscle ryanodine receptor as a target of stress.
    Bellinger AM; Mongillo M; Marks AR
    J Clin Invest; 2008 Feb; 118(2):445-53. PubMed ID: 18246195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ion-regulatory membrane proteins of excitation-contraction coupling and relaxation in inherited muscle diseases.
    Froemming GR; Ohlendieck K
    Front Biosci; 2001 Jan; 6():D65-74. PubMed ID: 11145921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells.
    Greer LK; Meilleur KG; Harvey BK; Wires ES
    Orphanet J Rare Dis; 2022 Jun; 17(1):225. PubMed ID: 35698232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors.
    Fruen BR; Mickelson JR; Louis CF
    J Biol Chem; 1997 Oct; 272(43):26965-71. PubMed ID: 9341133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
    Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel targets for treating heart and muscle disease: stabilizing ryanodine receptors and preventing intracellular calcium leak.
    Lehnart SE
    Curr Opin Pharmacol; 2007 Apr; 7(2):225-32. PubMed ID: 17306622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex].
    Lunardi J; Monnier N
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S70-7. PubMed ID: 15269663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ryanodine receptor channelopathies.
    Benkusky NA; Farrell EF; Valdivia HH
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired calcium release during fatigue.
    Allen DG; Lamb GD; Westerblad H
    J Appl Physiol (1985); 2008 Jan; 104(1):296-305. PubMed ID: 17962573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant hyperthermia].
    Takagi A
    Ryoikibetsu Shokogun Shirizu; 2001; (36):423-9. PubMed ID: 11596428
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
    Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Ca(2+) sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin.
    Fruen BR; Bardy JM; Byrem TM; Strasburg GM; Louis CF
    Am J Physiol Cell Physiol; 2000 Sep; 279(3):C724-33. PubMed ID: 10942723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle.
    O'Driscoll S; McCarthy TV; Eichinger HM; Erhardt W; Lehmann-Horn F; Herrmann-Frank A
    Biochem J; 1996 Oct; 319 ( Pt 2)(Pt 2):421-6. PubMed ID: 8912676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.
    Sato K; Pollock N; Stowell KM
    Anesthesiology; 2010 Jun; 112(6):1350-4. PubMed ID: 20461000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
    Avila G; Dirksen RT
    J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of congestive heart failure on Ca2+ handling in skeletal muscle during fatigue.
    Lunde PK; Sejersted OM; Thorud HM; Tønnessen T; Henriksen UL; Christensen G; Westerblad H; Bruton J
    Circ Res; 2006 Jun; 98(12):1514-9. PubMed ID: 16690878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [King syndrome].
    Sano M
    Ryoikibetsu Shokogun Shirizu; 2001; (36):430-2. PubMed ID: 11596430
    [No Abstract]   [Full Text] [Related]  

  • 20. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes.
    Wehner M; Rueffert H; Koenig F; Meinecke CD; Olthoff D
    Cell Calcium; 2003 Aug; 34(2):163-8. PubMed ID: 12810058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.